Presentation Information
[Pj-062-2]Care partners' perceptions of amyloid targeting therapy for Alzheimer's disease with stopping dosing
Sadao Katayama1, Masashi Tsujimoto2, Keisuke Suzuki2, Kaname Ueda3, Manaka Sato3, Kanako Shimoura4, Shintaro Suo4, Naohisa Hatakeyama3 (1.Katayama Medical Clinic, Japan, 2.National Center for Geriatrics and Gerontology, Japan, 3.Eli Lilly Japan K.K., Japan, 4.Mebix, Inc., Japan)